Balchem

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in Montvale, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Balchem reports record 2022 earnings, eyes growth amid challenges

Balchem's strong performance in 2022, driven by record sales and earnings, positions them well for future growth. Strategic acquisitions and market studies provide opportunities for expansion despite temporary challenges.

Balchem reports record Q1 revenues, navigates market challenges strategically

Balchem's Q1 2023 performance reflects solid financial results, operational efficiency, and progress in sustainability initiatives.
Despite market challenges, the company showcased resilience, innovation, and a strategic focus on long-term growth.
Opportunities for growth and differentiation exist through market expansion, product innovation, and continued sustainability efforts.
Balchem's strong financial foundation, coupled with a commitment to sustainability, underpins its strategic positioning for future success.

Balchem reports stable Q2 earnings, eyes growth in nutrition sector

Balchem delivered a mixed performance in Q2 2023 with revenue decline but improved profitability metrics.
The company faces challenges in revenue growth and leadership transition but maintains financial stability.
Opportunities lie in exploring new markets, leveraging cash reserves, and capitalizing on manufacturing investments.

Balchem (BCPC) reports solid Q3 results amid market challenges

Balchem's Q3 performance reflects resilience amidst challenges, with a focus on innovation, quality, and operational efficiency.
While facing market uncertainties and higher interest expenses, the company's strategic strengths in key segments position it for growth.
Opportunities lie in leveraging partnerships, consumer awareness efforts, and strategic initiatives to drive future sales and profitability.

Balchem reports record earnings in Q4 2023, eyes growth opportunities

Balchem's Q4 2023 performance showcased resilience with record earnings and strong profitability despite challenges in certain segments. Strategic initiatives and focus on sustainability and growth areas like Human Nutrition & Health position the company well for future success. Optimism for 2024 and potential partnerships signal a promising outlook for Balchem.

Balchem reports robust Q1 earnings, focuses on growth strategies

Balchem's Q1 2024 performance reflects strong financial results, driven by record sales and adjusted EBITDA, despite challenges in specific segments.
The company's focus on sustainability, marketing initiatives, and margin improvement positions it well for future growth and market expansion.
Addressing challenges in the Animal Nutrition & Health segment while leveraging opportunities in key segments like Human Nutrition & Health is crucial for sustained success.
Balchem's strategic partnerships, marketing efforts, and participation in investor conferences signal a proactive approach to driving growth and enhancing shareholder value.

Balchem reports solid Q2 earnings, eyes growth amid segment challenges

Balchem's Q2 2024 performance reflects resilience and growth, particularly in the Human Nutrition & Health and Specialty Products segments, despite challenges in the Animal Nutrition & Health segment.
The company's focus on innovation, debt reduction, and operational efficiency positions it well for future opportunities and sustained financial strength.
With a solid financial foundation, Balchem is poised to navigate challenges, capitalize on growth opportunities, and drive value for shareholders in the coming quarters.

Balchem (BCPC) reports record earnings, eyes growth amid margin challenges

Balchem (BCPC) delivered strong financial results in Q3 2024, driven by solid performance across its segments and successful new product launches. While anticipating margin moderation, the company remains optimistic about continued growth opportunities, especially in key segments. Balchem's focus on strategic investments and market stability positions it well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ.

NEW HAMPTON, N.Y., April 30, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today first quarter 2021 net earnings of $23.4 million, compared to net earnings of $19.8 million for the first quarter 2020, adjusted net earnings(a) of $28.4 million, compared to $26.4 million in the prior year quarter, and adjusted EBITDA(a) of $45.7 million, compared to $42.4 million in the prior year quarter.

Balchem Corporation Reports Record First Quarter Sales of $185.7 Million, Net Earnings of $23.4 Million, GAAP EPS of $0.72, and Adjusted EPS of $0.87

NEW HAMPTON, N.Y., April 26, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today released its 2020 Sustainability Report, which captures the Company's commitment to managing our Environmental, Social and Governance (ESG) performance. This report demonstrates the Company's continuing promise to provide our employees, customers, shareholders and the communities within which we operate with information on Balchem's sustainability initiatives.

Balchem Releases 2020 Sustainability Report

NEW HAMPTON, N.Y., April 16, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, April 30 at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO will host the call.

Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on April 30, 2021

Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Blachem (BCPC) Upgraded to Strong Buy: Here's Why

Bio-Rad Laboratories

Reata Pharmaceuticals

Benjamin Graham, the father of value investing, recommended to stick to stocks that have a current ratio of more than 2 and more working capital than long-term debt.

3 High-Quality Picks for the Value Investor

NEW HAMPTON, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the J.P. Morgan Industrials Conference on March 15, 2021. Balchem's presentation will begin at 9:40 a.m. (ET).

Balchem Corporation to Present at the J.P. Morgan Industrials Conference on March 15, 2021

Balchem's (BCPC) CEO Ted Harris on Q4 2020 Results - Earnings Call Transcript

Blachem (BCPC) delivered earnings and revenue surprises of 23.88% and -0.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Blachem (BCPC) Q4 Earnings Top Estimates

NEW HAMPTON, N.Y., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today fourth quarter net earnings of $22.2 million for 2020, compared to net earnings of $20.4 million for the fourth quarter 2019. Fourth quarter adjusted net earnings(a) were $26.9 million, compared to $28.4 million in the prior year quarter. Fourth quarter adjusted EBITDA(a) was $43.6 million, compared to $40.0 million in the prior year quarter. Balchem Corporation also reported for the full year 2020 net earnings of $84.6 million, compared to net earnings of $79.7 million for 2019. Full year adjusted net earnings(a) were $107.8 million, compared to $103.7 million in the prior year, and full year adjusted EBITDA(a) was $174.2 million, compared to $160.0 million in the prior year.

Balchem Corporation Reports Record Fourth Quarter Sales of $180.7 Million and Net Earnings of $22.2 Million, GAAP EPS of $0.68 and Adjusted EPS of $0.83

Balchem (NASDAQ:BCPC) unveils its next round of earnings this Friday, February 19. Here is Benzinga's everything-that-matters guide for the earnings announcement.

Earnings Preview for Balchem

Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Blachem (BCPC) to Report a Decline in Earnings: What to Look Out for

NEW HAMPTON, N.Y., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 19 at 11:00 AM Eastern Time (ET) to review fourth quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO will host the call.

Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 19, 2021

NEW HAMPTON, N.Y., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the Sidoti & Company LLC Virtual Investor Conference on Wednesday, January 13, 2021. Balchem's presentation will begin at 1:45 p.m. (EDT).

Balchem Corporation to Present at Sidoti & Company LLC Virtual Investor Conference on January 13, 2021

ABM Industries

Acme United

Amgen

Franklin Resources

City Hld

Ensign Group

Eli Lilly

Washington Trust Bancorp

This weekly article series covers dividend changes. A summary table provides relevant data and key statistics of dividend increases.

Dividend Changes: December 12-18, 2020

Blachem (BCPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Blachem (BCPC) Upgraded to Buy: Here's Why

NEW HAMPTON, N.Y., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at Stephens Annual Investment Conference 2020 on Tuesday, November 17, 2020. Balchem's presentation will begin at 2:00 p.m. (EST).

Balchem Corporation to Present at Stephens Annual Investment Conference 2020 on November 17, 2020

NEW HAMPTON, N.Y., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at Baird's 2020 Global Industrial Conference on Thursday, November 12, 2020. Balchem's presentation will begin at 12:50 p.m. (EST).

Balchem Corporation to Present at Baird's 2020 Global Industrial Conference November 12, 2020

Balchem Corporation (BCPC) CEO Ted Harris on Q3 2020 Results - Earnings Call Transcript

Blachem (BCPC) delivered earnings and revenue surprises of 23.88% and -1.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Blachem (BCPC) Q3 Earnings Top Estimates

NEW HAMPTON, N.Y., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today record third quarter net earnings of $21.6 million for 2020, compared to net earnings of $20.7 million for the third quarter 2019.  Record third quarter adjusted net earnings(a) were $26.9 million, compared to $26.3 million in the prior year quarter, and all time record adjusted EBITDA(a) was $44.4 million, compared to $40.4 million in the prior year quarter.

Balchem Corporation Reports Record Third Quarter Sales of $175.1 Million, Net Earnings of $21.6 Million, GAAP EPS of $0.66, and Adjusted EPS of $0.83

NEW HAMPTON, N.Y., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Wednesday, October 28, 2020 at 11:00 AM Eastern Time (ET) to review third quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO will host the call.

Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 28, 2020

NEW HAMPTON, N.Y., Sept.  23, 2020  (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at Morningstar's Management Behind the Moat Conference on Tuesday, September 29, 2020. Balchem’s presentation will begin at 9:00 a.m. (EDT).

Balchem Corporation to Present at Morningstar's Management Behind the Moat Conference September 29, 2020

NEW HAMPTON, N.Y., Sept.  15, 2020  (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the Sidoti Fall 2020 Virtual Investor Conference on Wednesday, September 23, 2020.  Balchem’s presentation will begin at 2:30 p.m. (EDT).

Balchem Corporation to Present at the Sidoti Fall 2020 Virtual Investor Conference on September 23, 2020

Balchem Corporation Is An Unheard Of Growing Machine

Blachem (BCPC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

News for Balchem Stock (BCPC)